FIGO stage IIB cervical cancer prognostication in low‐resource settings

2020 ◽  
Vol 149 (2) ◽  
pp. 254-254
Author(s):  
Sean Kehoe ◽  
Neerja Bhatla ◽  
Keyword(s):  
Cervical Cancer ◽  
Figo Stage ◽  
Low Resource Settings ◽  
Low Resource

Revised (2018) FIGO stage IIB cervical cancer and prognostication in low‐resource settings

2020 ◽  
Vol 149 (2) ◽  
pp. 252-253 ◽  
Author(s):  
Ishak Kayode Lawal ◽  
Habiba Ibrahim Abdullahi ◽  
Augustus Chiemeze Obiokonkwo
Keyword(s):  
Cervical Cancer ◽  
Figo Stage ◽  
Low Resource Settings ◽  
Low Resource

Use of Smartphones as Adjuvant Tools for Cervical Cancer Screening in Low-Resource Settings

2015 ◽  
Vol 19 (4) ◽  
pp. 295-300 ◽  
Author(s):  
Dominique Ricard-Gauthier ◽  
Anna Wisniak ◽  
Rosa Catarino ◽  
Annabelle Faure van Rossum ◽  
Ulrike Meyer-Hamme ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Low Resource Settings ◽  
Low Resource

Comparison of Papanicolaou Test With Visual Detection Tests in Screening for Cervical Cancer and Developing the Optimal Strategy for Low Resource Settings

2010 ◽  
Vol 20 (5) ◽  
pp. 862-868 ◽  
Author(s):  
Pakhee Aggarwal ◽  
Swaraj Batra ◽  
Gauri Gandhi ◽  
Vijay Zutshi
Keyword(s):  
Cervical Cancer ◽  
Predictive Value ◽  
Visual Inspection ◽  
Visual Detection ◽  
Alternative Methods ◽  
Papanicolaou Test ◽  
Low Resource Settings ◽  
Low Resource ◽  
The Mean ◽  
Sensitivity Specificity

Objectives:To compare the sensitivity, specificity, positive and negative predictive values, and accuracy of Papanicolaou test with visual inspection with acetic acid (VIA)/VIA using magnification devices (VIAM) and develop the best strategy for screening in low resource settings.Materials and Methods:This is a prospective cross-sectional study on 408 symptomatic multiparous women in the reproductive age group, sequentially using the Papanicolaou test, the VIA, and the VIAM for screening. Women with a positive screening test underwent guided biopsy and endocervical curettage. The site of biopsy was recorded. Histopathological findings were taken as the "gold" standard in comparing the methods.Results:The mean (SD) age was 32.3 (6.8) years (range, 15-49 years), whereas the mean (SD) parity was 2.9 (1.2) (range, 1-9). Abnormal cytological findings were detected in 2.9% patients, whereas the remaining smears were negative for any intraepithelial lesion or malignancy. A total of 113 cases were screened positive by one/all methods. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of the Papanicolaou test, the VIA, and the VIAM were 24, 98, 42, 96, and 94%; 95, 78, 19, 99, and 79%; and 95, 78, 19, 99, and 79%, respectively, for high-grade lesions.Conclusions:The Papanicolaou test had low sensitivity but high specificity, whereas visual detection methods had a high sensitivity in addition to being cheaper. Alternative methods of screening such as VIA/VIAM can be a valuable alternative to the Papanicolaou test for cervical cancer screening in low resource settings. Visual inspection using magnification devices may be of benefit over VIA in doubtful cases.

Adjunctive testing for cervical cancer in low resource settings with visual inspection, HPV, and the Pap smear

2001 ◽  
Vol 72 (1) ◽  
pp. 47-53 ◽  
Author(s):  
P.D. Blumenthal ◽  
L. Gaffikin ◽  
Z.M. Chirenje ◽  
J. McGrath ◽  
S. Womack ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Visual Inspection ◽  
Pap Smear ◽  
Low Resource Settings ◽  
Low Resource

scholarly journals Cervical cancer treatment in Haiti: A vertically-integrated model for low-resource settings

2019 ◽  
Vol 28 ◽  
pp. 71-75 ◽  
Author(s):  
Vincent DeGennaro ◽  
Madelyn Shafer ◽  
Meagan Kelly ◽  
Jean Ronald Cornely ◽  
Joseph Bernard
Keyword(s):  
Cervical Cancer ◽  
Cancer Treatment ◽  
Integrated Model ◽  
Low Resource Settings ◽  
Low Resource

scholarly journals Speculum-Free Callascope for Cervical Self-Visualization: Acceptability, Feasibility, and Improved Awareness of the Reproductive System

2020 ◽  
Vol 6 (Supplement_1) ◽  
pp. 50-50
Author(s):  
Mary Elizabeth Dotson ◽  
Mercy Asiedu ◽  
Nimmi Ramanujam
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Low Cost ◽  
Invasive Cervical Cancer ◽  
Imaging Device ◽  
Low Resource Settings ◽  
Low Resource ◽  
Attitudes And Practices ◽  
Home Based

PURPOSE Invasive cervical cancer is preventable, yet it affects 500,000 women worldwide each year, and more than one half these women die. Barriers to cervical cancer screening include a lack of awareness of cervical cancer and the cervix, fear of the speculum, and lack of women-centric technologies. We developed a low-cost (approximately $50), cervix-imaging device called the Callascope, which consists of an imaging component, camera, and inserter that obviates the need for a speculum and enables self-insertion. Studies are lacking regarding women’s willingness to independently image their cervix and women’s ability to effectively use the Callascope for self-imaging. METHODS We conducted two studies: in-depth interviews to assess the willingness to self-image the cervix, perceptions of the Callascope, and knowledge, attitudes, and practices toward cervical cancer screening; and home-based self-cervix imaging with the Callascope where women recorded an audio reflection on their experience. RESULTS Participants in interviews (n = 12) and home study (n = 12) all indicated a preference for the Callascope over the speculum. Interview data demonstrated that 53% of participants had little knowledge of basic reproductive anatomy, and only 17% of participants understood that human papillomavirus was a direct cause of cervical cancer. Self-exam data showed that 83% of participants were able to visualize their cervix with the Callascope on the first try and 100% were able to do so by the end of the study. Of participants, 100% indicated that the home exam was an empowering and informative experience. CONCLUSION The Callascope is more comfortable than the speculum and women are able to successfully image their cervices from home without the need for a speculum. With improved diagnostic capabilities, the Callascope could be used by medical providers for clinical exams, particularly in low-resource settings, as a low-cost and more comfortable alternative to the SOC. The Callascope enables home self-screening for cervical cancer and a better understanding of one’s body, which could make screening more accessible in low-resource settings.

Sign in / Sign up

Export Citation Format

Share Document